According to Heidelberg Pharma's latest financial reports the company's current EPS (TTM) is -$0.57. In 2023 the company made an earnings per share (EPS) of -$0.48 an increase over its 2022 EPS that were of -$0.55.
Year | EPS | Change |
---|---|---|
2024 (TTM) | -$0.57 | 17.87% |
2023 | -$0.48 | -11.76% |
2022 | -$0.55 | -39.43% |
2021 | -$0.90 | 23.72% |
2020 | -$0.73 | 84.11% |
2019 | -$0.40 | -15.08% |
2018 | -$0.47 | -48.14% |
2017 | -$0.90 | 66.12% |
2016 | -$0.54 | -28.79% |
2015 | -$0.76 | -7.14% |
2014 | -$0.82 | -0.23% |
2013 | -$0.82 | -53.41% |
2012 | -$1.76 | -47.68% |
2011 | -$3.37 | -49.85% |
2010 | -$6.72 | 26.57% |
2009 | -$5.31 | -35.08% |
2008 | -$8.18 | -19.49% |
2007 | -$10.16 | -11.09% |
2006 | -$11.43 |